Intra-articular Hyaluronan Substitution in Arthroscopy of the Wrist
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Faktiske)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Bavaria
-
Straubing, Bavaria, Tyskland, 94315
- Orthopädische Gemeinschaftspraxis
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Male and female patients between 18 and 80 years of age
- Minimum pain score of 2 according to modified Mayo Wrist Score
- Patients in good general health/nutritional condition
- Signed written informed consent
Exclusion Criteria:
- Alcohol / drug abuse, drug addiction or neurotic personality disorder; patients with mental illness or suicidal tendency
- Severe intercurrent illness (like uncontrolled diabetes mellitus or thyroid disease, carcinoma,...)
- Fertile women without medically secured contraception(hysterectomy, sterilization, contraceptives,...)
- Subjects having a high probability of non compliance to the study procedures according to investigator's judgement (like illiteracy, insufficient German linguistic knowledge)
- Contraindication for the use of one of the investigational products or for the scheduled anesthesia
- Concomitant or previous participation in a clinical trial within the last 3 months
- Intraarticular treatment with a sodium hyaluronate-based product within the last 6 months
- Intraarticular treatment by the use of corticoid containing substance within the last 3 months
- Concomitant illness or injury influencing study evaluation
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Aktiv komparator: Hyaluronic acid sodium salt (1%, 20mg/2ml)
|
Standard arthroscopy (including intra-articular injection of 5 ml scandicain (0,5%), or 5 ml bupivacain plus 5 ml suprarenin in case of post-arthroscopic treatment).
Add-on treatment with Ostenil after standard arthroscopic procedure.
Application twice: first injection directly after arthroscopic procedure and second injection 3 weeks post arthroscopic.
|
|
Annen: Standard arthroscopic procedure
|
Standard arthroscopy (including intra-articular injection of 5 ml scandicain (0,5%), or 5 ml bupivacain plus 5 ml suprarenin in case of post-arthroscopic treatment) without add-on treatment.
|
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Inter-group comparison of Mayo total wrist score in subjects with or without post-arthroscopic hyaluronan treatment 3 months after arthroscopic surgery.
Tidsramme: Baseline and 3 months
|
Mayo wrist score evaluation consisting of 4 sections:
|
Baseline and 3 months
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Inter-group comparison of Mayo total wrist score in subjects with or without post-arthroscopic hyaluronan treatment.
Tidsramme: Measured during the 6-month duration of participation
|
Measured during the 6-month duration of participation
|
|
|
Disabilities of the arm, shoulder, and hand (DASH) outcome measure
Tidsramme: Measured during the 6-month duration of participation
|
Measured during the 6-month duration of participation
|
|
|
Grip strength
Tidsramme: Measured during the 6-month duration of participation
|
Measured during the 6-month duration of participation
|
|
|
Visual analogue scale of pain (VAS; 100 mm)
Tidsramme: Measured during the 6-month duration of participation
|
Measured during the 6-month duration of participation
|
|
|
Clinical Global Impression (CGI)
Tidsramme: Measured during the 6-month duration of participation
|
Measured during the 6-month duration of participation
|
|
|
Inter-group comparison of Mayo wrist subscores in subjects with or without post-arthroscopic hyaluronan treatment.
Tidsramme: Measured during the 6-month duration of participation
|
|
Measured during the 6-month duration of participation
|
|
Number of subjects with Adverse Events as a measure of safety and tolerability
Tidsramme: Measured during the 6-month duration of participation
|
Measured during the 6-month duration of participation
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Hovedetterforsker: Alexander Schütz, Dr. med., Orthopädische Gemeinschaftspraxis, Straubing (Germany)
Studierekorddatoer
Studer hoveddatoer
Studiestart
Studiestart
Primær fullføring (Faktiske)
Primær fullføring
Studiet fullført (Faktiske)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
Andre studie-ID-numre
- OSTWA-07-01
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .